Fortitude Family Office’s KALA BIO KALA Stock Holding History

Fortitude Family Office’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$394	–	1990
2025 Q4	$394	Buy	+14	New	+$627	﹤0.01%	1773

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fortitude Family Office's KALA Position: Q1 2026 in Review

Fortitude Family Office sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 14 shares — an estimated $394 sold.

Fortitude Family Office first reported a position in KALA in Q4 2025 and held it in 1 quarter. The position peaked at $394 in Q4 2025. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

Fortitude Family Office reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
Fortitude Family Office sold 14 KALA BIO shares in Q1 2026, an estimated $394.
Fortitude Family Office first reported a position in KALA BIO in Q4 2025 and held it in 1 quarter.
Fortitude Family Office's KALA BIO position peaked at $394 in Q4 2025.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.